Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay. (Q37358618)
Jump to navigation
Jump to search
scientific article published on 22 August 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay. |
scientific article published on 22 August 2016 |
Statements
Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay (English)
Mizuki Yamamoto
1 reference
Xiao Li
Jun-Ichiro Inoue
21 October 2016